ebomi
Colour theme
Sign in
Insider · CIK 0001298034

DP VI Associates, L.P.

CIK 0001298034 Name as filed on the most recent filing

Filed as DP VI Associates, L.P. (29)

49 transaction lines · from 29 filings · filed 2006-09-20 to 2016-08-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

4 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-08-03 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 1,051, disposed Open Form 4 filing 0000904454-16-001354
2016-08-02 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 279, disposed Open Form 4 filing 0000904454-16-001354
2016-08-01 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 741, disposed Open Form 4 filing 0000904454-16-001354
2016-04-28 S, Open-market sale CoLucid Pharmaceuticals, Inc.CLCD 1,636, disposed Open Form 4 filing 0000904454-16-001194
2014-01-16 S, Open-market sale Alimera Sciences IncALIM 14,629, disposed Open Form 4 filing 0000904454-14-000081
2014-01-15 S, Open-market sale Alimera Sciences IncALIM 6,070, disposed Open Form 4 filing 0000904454-14-000081
2013-06-20 S, Open-market sale Alimera Sciences IncALIM 571, disposed Open Form 4 filing 0000904454-13-000717
2013-06-19 S, Open-market sale Alimera Sciences IncALIM 1,310, disposed Open Form 4 filing 0000904454-13-000713
2013-06-18 S, Open-market sale Alimera Sciences IncALIM 1,939, disposed Open Form 4 filing 0000904454-13-000713
2013-06-17 S, Open-market sale Alimera Sciences IncALIM 5,179, disposed Open Form 4 filing 0000904454-13-000703
2013-06-14 S, Open-market sale Alimera Sciences IncALIM 2,138, disposed Open Form 4 filing 0000904454-13-000703
2013-06-11 S, Open-market sale Alimera Sciences IncALIM 295, disposed Open Form 4 filing 0000904454-13-000691
2013-05-16 S, Open-market sale Alimera Sciences IncALIM 1,044, disposed Open Form 4 filing 0000904454-13-000584
2013-05-15 S, Open-market sale Alimera Sciences IncALIM 1,180, disposed Open Form 4 filing 0000904454-13-000584
2013-03-21 S, Open-market sale Cadence Pharmaceuticals IncCADX 9,569, disposed Open Form 4 filing 0000904454-13-000469
2013-03-20 S, Open-market sale Cadence Pharmaceuticals IncCADX 950, disposed Open Form 4 filing 0000904454-13-000461
2013-03-19 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,355, disposed Open Form 4 filing 0000904454-13-000461
2013-03-18 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,367, disposed Open Form 4 filing 0000904454-13-000451
2013-03-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,679, disposed Open Form 4 filing 0000904454-13-000451
2013-03-14 S, Open-market sale Cadence Pharmaceuticals IncCADX 890, disposed Open Form 4 filing 0000904454-13-000441
2013-03-13 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,382, disposed Open Form 4 filing 0000904454-13-000441
2013-03-12 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,130, disposed Open Form 4 filing 0000904454-13-000433
2013-03-11 S, Open-market sale Cadence Pharmaceuticals IncCADX 726, disposed Open Form 4 filing 0000904454-13-000433
2013-03-08 S, Open-market sale Cadence Pharmaceuticals IncCADX 910, disposed Open Form 4 filing 0000904454-13-000405
2013-03-07 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,192, disposed Open Form 4 filing 0000904454-13-000405
2013-03-06 S, Open-market sale Cadence Pharmaceuticals IncCADX 643, disposed Open Form 4 filing 0000904454-13-000393
2013-03-05 S, Open-market sale Cadence Pharmaceuticals IncCADX 671, disposed Open Form 4 filing 0000904454-13-000393
2013-03-04 S, Open-market sale Cadence Pharmaceuticals IncCADX 852, disposed Open Form 4 filing 0000904454-13-000378
2013-03-01 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,268, disposed Open Form 4 filing 0000904454-13-000378
2013-02-20 S, Open-market sale Cadence Pharmaceuticals IncCADX 331, disposed Open Form 4 filing 0000904454-13-000317
2013-02-19 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,677, disposed Open Form 4 filing 0000904454-13-000309
2013-02-15 S, Open-market sale Cadence Pharmaceuticals IncCADX 495, disposed Open Form 4 filing 0000904454-13-000309
2013-02-14 S, Open-market sale Cadence Pharmaceuticals IncCADX 491, disposed Open Form 4 filing 0000904454-13-000297
2013-02-13 S, Open-market sale Cadence Pharmaceuticals IncCADX 955, disposed Open Form 4 filing 0000904454-13-000297
2013-02-01 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,562, disposed Open Form 4 filing 0000904454-13-000161
2013-01-31 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,887, disposed Open Form 4 filing 0000904454-13-000150
2013-01-30 S, Open-market sale Cadence Pharmaceuticals IncCADX 1,835, disposed Open Form 4 filing 0000904454-13-000150
2013-01-29 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,672, disposed Open Form 4 filing 0000904454-13-000136
2013-01-28 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,975, disposed Open Form 4 filing 0000904454-13-000136
2013-01-25 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,453, disposed Open Form 4 filing 0000904454-13-000132
2013-01-24 S, Open-market sale Cadence Pharmaceuticals IncCADX 6,545, disposed Open Form 4 filing 0000904454-13-000132
2013-01-23 S, Open-market sale Cadence Pharmaceuticals IncCADX 4,287, disposed Open Form 4 filing 0000904454-13-000086
2013-01-22 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,485, disposed Open Form 4 filing 0000904454-13-000086
2013-01-18 S, Open-market sale Cadence Pharmaceuticals IncCADX 3,275, disposed Open Form 4 filing 0000904454-13-000064
2013-01-17 S, Open-market sale Cadence Pharmaceuticals IncCADX 2,236, disposed Open Form 4 filing 0000904454-13-000064
2011-06-02 S, Open-market sale Alimera Sciences IncALIM 55,589, disposed Open Form 4 filing 0000904454-11-000271
2006-12-21 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 87,326, disposed Open Form 4 filing 0000904454-06-000945
2006-12-12 S, Open-market sale Vanda Pharmaceuticals Inc.VNDA 330,498, disposed Open Form 4 filing 0000904454-06-000915
2006-09-18 S, Open-market sale Somaxon Pharmaceuticals, Inc.SOMX 84,161, disposed Open Form 4 filing 0000904454-06-000607

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 4
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DP VI Associates, L.P., insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001298034

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.